UY32639A - Un método para mantener una composicion inmunogénica disponible para que sea administrada a un animal - Google Patents

Un método para mantener una composicion inmunogénica disponible para que sea administrada a un animal

Info

Publication number
UY32639A
UY32639A UY0001032639A UY32639A UY32639A UY 32639 A UY32639 A UY 32639A UY 0001032639 A UY0001032639 A UY 0001032639A UY 32639 A UY32639 A UY 32639A UY 32639 A UY32639 A UY 32639A
Authority
UY
Uruguay
Prior art keywords
animal
administered
composition
maintain
temperature
Prior art date
Application number
UY0001032639A
Other languages
English (en)
Inventor
Visser Nicolaas
Jansen Theodorus
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of UY32639A publication Critical patent/UY32639A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a un método para mantener una composición inmunológica disponible para ser administrada a un animal, donde dicha composición comprende un antígeno y a una emulsión que es una emulsión simple primera temperatura por debajo de una temperatura corporal del animal y que se invierte a una segunda temperatura entre la primera temperatura y la temperatura corporal, donde dicho método comprende proveer la composición, congelar la composición y almacenar la composición congelada hasta que sea necesario administrarla al animal.
UY0001032639A 2009-05-18 2010-05-14 Un método para mantener una composicion inmunogénica disponible para que sea administrada a un animal UY32639A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09160451 2009-05-18
US17954809P 2009-05-19 2009-05-19

Publications (1)

Publication Number Publication Date
UY32639A true UY32639A (es) 2010-12-31

Family

ID=41718978

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032639A UY32639A (es) 2009-05-18 2010-05-14 Un método para mantener una composicion inmunogénica disponible para que sea administrada a un animal

Country Status (8)

Country Link
US (1) US9408804B2 (es)
EP (1) EP2432498B1 (es)
AR (1) AR076871A1 (es)
BR (1) BRPI1012122B1 (es)
RU (1) RU2530582C2 (es)
TW (1) TWI527598B (es)
UY (1) UY32639A (es)
WO (1) WO2010133592A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120070459A1 (en) * 2010-09-22 2012-03-22 Goovaerts Daniel G E Method for keeping a foot-and-mouth disease vaccine available for emergency vaccination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU770475B2 (en) * 1999-12-23 2004-02-19 Aphton Corporation A stable immunogenic composition for frozen storage
FR2814956B1 (fr) * 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
US7998488B2 (en) * 2008-11-14 2011-08-16 Baxter International Inc. Vaccine formulations and uses thereof

Also Published As

Publication number Publication date
TWI527598B (zh) 2016-04-01
TW201105364A (en) 2011-02-16
AR076871A1 (es) 2011-07-13
RU2011151629A (ru) 2013-06-27
BRPI1012122A2 (pt) 2016-03-29
US20120087945A1 (en) 2012-04-12
EP2432498A1 (en) 2012-03-28
RU2530582C2 (ru) 2014-10-10
EP2432498B1 (en) 2014-05-14
BRPI1012122B1 (pt) 2021-06-15
WO2010133592A1 (en) 2010-11-25
US9408804B2 (en) 2016-08-09

Similar Documents

Publication Publication Date Title
CY1123852T1 (el) Αλατα ή συγκρυσταλλοι της 3-(3-διμεθυλαμινο-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
AR082586A1 (es) Productos dulces no perecederos
PE20190914A1 (es) Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico
UY34091A (es) Uso de nitratos y sulfatos encapsulados para reducir la emisión de metano que se deriva de la fermentación ruminal
AR059922A1 (es) Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos
PE20131026A1 (es) Proceso para la recuperacion de compuestos oleaginosos a partir de biomasa
PE20131411A1 (es) Anticuerpos contra la tweak humana y usos de los mismos
PE20191242A1 (es) Formulaciones de anticuerpo y metodos
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
CL2021000827A1 (es) Métodos para reducir la agregación de anticuerpos biespecíficos
CR20160235A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
EA201500701A1 (ru) Способ создания вакцины против микоплазм
CL2021002676A1 (es) Nutrición en los primeros años
AR067432A1 (es) Una composicion de hidroxido de litio, un proceso para su preparacion, y un proceso para su utilizacion
UY32639A (es) Un método para mantener una composicion inmunogénica disponible para que sea administrada a un animal
AR095594A1 (es) Métodos para tratar infecciones en pacientes con sobrepeso y obesos usando antibióticos
CL2012003105A1 (es) Bacteria comensal geneticamente diseñada, del tracto genital femenino que expresa un agente anti espermatozoide; composicion que comprende dicha bacteria; uso de dicha composicion para la reduccion de la incidencia de embarazo en una poblacion femenina; dispositivo de insercion intravaginal.
CL2017001679A1 (es) Uso de extractos de quillaja saponaria para la prevención y control de infecciones bacterianas en peces
AR101442A1 (es) Método para la expansión de células madre de adultos de sangre
RU2013118288A (ru) Способ сохранения вакцины против ящура, доступной для экстренной вакцинации
ES2565637T3 (es) Método de obtención de nanocristales de fluorapatita facetados
CL2015001368A1 (es) Metodo para anticoncepcion controlada que comprende administrar una preparacion farmaceutica que comprende levonorgestrel y un inhibidor de la cox; uso de la composicion farmaceutica en la anticoncepcion "a la carta".
BRPI0920984A2 (pt) Método para reduzir trombocitopenia e trombocitopenia associada à mortalidade.
UY32621A (es) Antígeno glicano
RU2012138835A (ru) Способ получения очищенного соматического антигена dirofilaria immitis

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181129